Beijing Wantai (China) Performance
| 603392 Stock | 66.88 0.16 0.24% |
The firm shows a Beta (market volatility) of -0.0227, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Beijing Wantai are expected to decrease at a much lower rate. During the bear market, Beijing Wantai is likely to outperform the market. At this point, Beijing Wantai Biological has a negative expected return of -0.19%. Please make sure to confirm Beijing Wantai's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Beijing Wantai Biological performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Beijing Wantai Biological has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Payout Ratio 10 | Last Split Factor 1.4:1 | Ex Dividend Date 2024-06-03 | Last Split Date 2023-06-05 |
| Begin Period Cash Flow | 5.2 B |
Beijing |
Beijing Wantai Relative Risk vs. Return Landscape
If you would invest 7,536 in Beijing Wantai Biological on December 19, 2024 and sell it today you would lose (832.00) from holding Beijing Wantai Biological or give up 11.04% of portfolio value over 90 days. Beijing Wantai Biological is generating negative expected returns and assumes 1.9637% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Beijing, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Beijing Wantai Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beijing Wantai's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beijing Wantai Biological, and traders can use it to determine the average amount a Beijing Wantai's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0948
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 603392 |
Estimated Market Risk
| 1.96 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Beijing Wantai is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beijing Wantai by adding Beijing Wantai to a well-diversified portfolio.
Beijing Wantai Fundamentals Growth
Beijing Stock prices reflect investors' perceptions of the future prospects and financial health of Beijing Wantai, and Beijing Wantai fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Beijing Stock performance.
| Return On Equity | -0.0226 | ||||
| Return On Asset | -0.0154 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 80.24 B | ||||
| Shares Outstanding | 1.27 B | ||||
| Price To Book | 6.83 X | ||||
| Price To Sales | 34.00 X | ||||
| Revenue | 5.51 B | ||||
| Gross Profit | 1.53 B | ||||
| EBITDA | (122.77 M) | ||||
| Net Income | 1.25 B | ||||
| Total Debt | 81.14 M | ||||
| Book Value Per Share | 9.35 X | ||||
| Cash Flow From Operations | 1.54 B | ||||
| Earnings Per Share | (0.23) X | ||||
| Total Asset | 15.71 B | ||||
| Retained Earnings | 7.57 B | ||||
About Beijing Wantai Performance
By analyzing Beijing Wantai's fundamental ratios, stakeholders can gain valuable insights into Beijing Wantai's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Beijing Wantai has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Beijing Wantai has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Beijing Wantai is entity of China. It is traded as Stock on SHG exchange.Things to note about Beijing Wantai Biological performance evaluation
Checking the ongoing alerts about Beijing Wantai for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beijing Wantai Biological help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Beijing Wantai generated a negative expected return over the last 90 days | |
| About 82.0% of the company shares are owned by insiders or employees |
- Analyzing Beijing Wantai's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beijing Wantai's stock is overvalued or undervalued compared to its peers.
- Examining Beijing Wantai's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Beijing Wantai's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beijing Wantai's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Beijing Wantai's stock. These opinions can provide insight into Beijing Wantai's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Beijing Stock analysis
When running Beijing Wantai's price analysis, check to measure Beijing Wantai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Wantai is operating at the current time. Most of Beijing Wantai's value examination focuses on studying past and present price action to predict the probability of Beijing Wantai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Wantai's price. Additionally, you may evaluate how the addition of Beijing Wantai to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |